As a total outsider from bit-land at a day of talks on longevity science & venture, I’m struck by how much the long build–measure–learn cycles dictate strategies & tactics. And by how much leverage accrues by shortening those cycles!
Age 1 is thrilling. age1.com
Conversation
Replying to
Have these talks shifted your estimated probability of us living long enough to live forever? If so, how?
1
Yes, though I still think it’s very unlikely for you and me. More relevant is my shifted expectation for the broader Kaplan-Meier curve. eg I was quite shocked to learn how rapidly cell senescence clearance went from first intervention (‘13) to an IPO (literally today: Unity)
1
Replying to
Did any methods for shortening build-measure-learn cycles stand out in particular?
1
I was excited about the experimentation platform. And I liked Circumvent Pharma's approach of targeting an accelerated form of a broader range of neurodegenerative diseases as a test-bed. And of course, Age 1 itself pressures the culture to be more rapid.
1